Your browser doesn't support javascript.
loading
Community Screening for High-Risk Human Papilloma Virus Infection using Self-Sampling and 'Point-Of-Care' Test.
Panta, Shilpa; Rajaram, Shalini; Heda, Ayush; Bhadoria, Ajeet Singh; Kalita, Deepjyoti; Chawla, Latika; Chaturvedi, Jaya.
Afiliação
  • Panta S; Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rishikesh, India.
  • Rajaram S; Department of Obstetrics and Gynaecology (Gynaecologic Oncology), All India Institute of Medical Sciences, Rishikesh, India.
  • Heda A; Department of Obstetrics and Gynaecology (Gynaecologic Oncology), All India Institute of Medical Sciences, Rishikesh, India.
  • Bhadoria AS; Department of Community and Family Medicine, All India Institute of Medical Sciences, Rishikesh, India.
  • Kalita D; Department of Microbiology, All India Institute of Medical Sciences, Guwahati, India.
  • Chawla L; Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rishikesh, India.
  • Chaturvedi J; Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rishikesh, India.
Asian Pac J Cancer Prev ; 25(2): 653-659, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-38415553
ABSTRACT

OBJECTIVE:

HR-HPV types 16 and 18 are responsible for pre-invasive and invasive lesions of the cervix, accounting for 70-80% of the total subtypes. The aim of this study was to investigate the prevalence of high-risk HPV subtypes 16 and 18 in self-collected vaginal samples using real-time micro-PCR and to study the acceptability of self-sampling.

METHODS:

Eligible women (30-65 years) were screened from a semi-urban area of Uttarakhand (India) using self-sampling. High-risk HPV genotypes (16/31 and 18/45) were tested using real-time micro-PCR technique with results available in one hour. The positive results were validated by standard RT-PCR for high-risk HPV 16, 18, separately and for 12 other high-risk genotypes, combined. Ease of the procedure, level of comfort, and recommendation to other women were studied and the acceptability of self-sampling was analyzed using the Likert scale.

RESULT:

Of 975 eligible women screened, 45 participants tested positive for HR-HPV (16/31,18/45) using real-time micro-PCR with a prevalence of 4.6%. Positive samples were further tested through routine RT-PCR and 60% were found to be HR-HPV 16 and 18 positive. For self-sampling, 96.72% (n=943) participants were 'very satisfied' and 94.15% (n=918) found self-sampling to be 'very comfortable' and 88.51% (n=863) stated that they will strongly recommend this test to other eligible women in the community.

CONCLUSION:

We conclude that HR-HPV testing with limited genotyping showed a prevalence of 4.6%, 60% of these were HPV 16/18 positive. Point of care testing was feasible in the community and self-sampling was acceptable.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus Limite: Female / Humans Idioma: En Revista: Asian Pac J Cancer Prev Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia País de publicação: Tailândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero / Infecções por Papillomavirus Limite: Female / Humans Idioma: En Revista: Asian Pac J Cancer Prev Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia País de publicação: Tailândia